Review on t(8;14)(q24;q32) in BPDCN, with data on clinics
Clinics and pathology
Disease Blastic plasmacytoid dendritic cell neoplasm (BPDCN) Note BPDCN has been known with various names, including agranular CD4+ natural killer (NK) leukemia, CD4+/CD56+ hematodermic neoplasm, and blastic NK lymphoma. BPDCN malignant cells are derived from the precursors of plasmacytoid dendritic cells. It most commonly involves the skin. BPDCN is an aggressive neoplasm. BPDCN is often associated with a complex karyotype (review in Meloni-Ehrig 2017).
Epidemiology
In a series of 41 patients with BPDCN, five had a MYC rearrangement confirmed by FISH, one had a t(X;8)(q24;q24), one had a t(3;8)(p25;q24), two had a t(6;8)(p21;q24) MYC/SUPT3H, and one had a t(8;14)(q24;q32) (Boddu et al., 2018) .
Clinics
The patient with a t(8;14)(q24;q32) was a 55 yearold male patient with skin involvement. He did not respond to treatment and died 12 months after diagnosis.
Cytogenetics
The t(8;14)(q24;q32) was the sole anomaly.
Genes involved and proteins

